CATEGORY

MENA

Latest Quantexa Decision Intelligence Platform Roadmap Puts Focus on Helping Enterprises and Government Agencies to Get Data Ready For AI

   Quantexa supporting rising wave of organizations using data, analytics, and AI to break down silos Partnership with Microsoft makes Quantexa’s Decision Intelligence Platform immediately available on Microsoft Azure Marketplace; company commits to build solutions natively on Azure Technology preview demonstrates Quantexa’s ambitious plan to accelerate platform, solution and generative

Continue Reading

Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners

Proposed divestiture of Endpoint Clinical and Fortrea Patient Access businesses further streamlines Fortrea’s strategic focus as a pure-play contract research organization Creates standalone best-in-class Randomization and Trial Supply Management and Patient Access solutions positioned for differentiation and growth DURHAM, N.C., March 11, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the

Continue Reading

Recursion Announces Plans to Open New Office in London

Appoints Michael Bronstein as Scientific Advisor and launches recruiting effort to fill the first 20 open roles across technology and biology, establishing a hub for world-class TechBio talent in the heart of King’s Cross neighborhood LONDON, March 11, 2024 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX), a leading clinical stage TechBio

Continue Reading

Dentsu Appoints Shirli Zelcer to Chief Data and Technology Officer

Steve Simpson joins as President, Data, Audiences and Technology; Shiva Vannavada appointed as President, Data and Technology Solutions Shirli Zelcer TOKYO, March 07, 2024 (GLOBE NEWSWIRE) — Dentsu (brand: dentsu; Head Office: Dentsu Group Inc.; Location: Tokyo; Representative: President and Global CEO Hiroshi Igarashi) today announced the appointment of Shirli

Continue Reading

Zenas BioPharma Appoints Patricia Allen to its Board of Directors

WALTHAM, Mass., March 06, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of inflammation and immunology-directed therapies, today announced the appointment of Patricia Allen to its Board of Directors, on which she also will serve as Chairperson of

Continue Reading

Recent Posts